Pelage Pharmaceuticals advances its clinical program

[Kagaho]

Pelage Pharmaceuticals Advances Clinical Program with First Patients Dosed in Phase 2 Study for Hair Loss and GV-Led $14M Series A-1

/PRNewswire/ -- Pelage Pharmaceuticals, a clinical-stage regenerative medicine company pioneering a new generation of treatments for hair loss, today announced...

www.prnewswire.com

New stuff. It targets hair follicle stem cells directly via a very crucial pathway.

 

[Modill]

After DSC Sisheido treatment, this is the best option. Thanks for sharing

 

[It_is_over_for_nw7]

Another future failed company I see.

 

[Modill]

Another future failed company I see.

Maybe. It is a topic treatment, not targeted.
This protein will go trough the blood making unknown side effects